BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35689214)

  • 1. Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults.
    Schechter M; Melzer Cohen C; Yanuv I; Rozenberg A; Chodick G; Bodegård J; Leiter LA; Verma S; Lambers Heerspink HJ; Karasik A; Mosenzon O
    Cardiovasc Diabetol; 2022 Jun; 21(1):104. PubMed ID: 35689214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease among US adults with type 2 diabetes and cardiovascular diseases: A national estimate of prevalence by KDIGO 2012 classification.
    Wang T; Xi Y; Lubwama R; Hannanchi H; Iglay K; Koro C
    Diabetes Metab Syndr; 2019; 13(1):612-615. PubMed ID: 30641775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney Function and Outcomes in Patients Hospitalized With Heart Failure.
    Patel RB; Fonarow GC; Greene SJ; Zhang S; Alhanti B; DeVore AD; Butler J; Heidenreich PA; Huang JC; Kittleson MM; Joynt Maddox KE; McDermott JJ; Owens AT; Peterson PN; Solomon SD; Vardeny O; Yancy CW; Vaduganathan M
    J Am Coll Cardiol; 2021 Jul; 78(4):330-343. PubMed ID: 33989713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohort : Rapid kidney function decline and heart failure in T2D.
    Bueno Junior CR; Bano A; Tang Y; Sun X; Abate A; Hall E; Mitri J; Morieri ML; Shah H; Doria A
    Cardiovasc Diabetol; 2023 Jun; 22(1):131. PubMed ID: 37365586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study.
    Pasea L; Dashtban A; Mizani M; Bhuva A; Morris T; Mamza JB; Banerjee A
    Open Heart; 2023 Sep; 10(2):. PubMed ID: 37758654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W; Xie D; Anderson AH; Joffe MM; Greene T; Teal V; Hsu CY; Fink JC; He J; Lash JP; Ojo A; Rahman M; Nessel L; Kusek JW; Feldman HI;
    Am J Kidney Dis; 2014 Feb; 63(2):236-43. PubMed ID: 24182662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study.
    Zareini B; Blanche P; D'Souza M; Elmegaard Malik M; Nørgaard CH; Selmer C; Gislason G; Kristensen SL; Køber L; Torp-Pedersen C; Schou M; Lamberts M
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006260. PubMed ID: 32571092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
    Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
    Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of chronic kidney disease in the Netherlands and its cardiovascular and renal complications.
    Vervloet MG; de Jong HJ; Pander J; Overbeek JA
    BMC Nephrol; 2023 Nov; 24(1):337. PubMed ID: 37957561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing for people with type 2 diabetes and renal impairment in Australian general practice: A national cross sectional study.
    Manski-Nankervis JE; Thuraisingam S; Sluggett JK; Lau P; Blackberry I; Ilomaki J; Furler J; Bell JS
    Prim Care Diabetes; 2019 Apr; 13(2):113-121. PubMed ID: 30262176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
    Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
    BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Kidney Function After Diagnosis of Advanced Heart Failure.
    Quiram BJ; Killian JM; Redfield MM; Smith J; Hickson LJ; Schulte PJ; Ngufor C; Dunlay SM
    J Card Fail; 2023 Dec; 29(12):1617-1625. PubMed ID: 37451601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.
    Mosenzon O; Wiviott SD; Cahn A; Rozenberg A; Yanuv I; Goodrich EL; Murphy SA; Heerspink HJL; Zelniker TA; Dwyer JP; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Kato ET; Gause-Nilsson IAM; Fredriksson M; Johansson PA; Langkilde AM; Sabatine MS; Raz I
    Lancet Diabetes Endocrinol; 2019 Aug; 7(8):606-617. PubMed ID: 31196815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function.
    Sullivan MK; Carrero JJ; Jani BD; Anderson C; McConnachie A; Hanlon P; Nitsch D; McAllister DA; Mair FS; Mark PB; Gasparini A
    BMC Med; 2022 Nov; 20(1):420. PubMed ID: 36320059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Bidirectional Association of Chronic Kidney Disease, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, and Heart Failure: The Cardio-Renal-Metabolic Syndrome.
    Nichols GA; Amitay EL; Chatterjee S; Steubl D
    Metab Syndr Relat Disord; 2023 Jun; 21(5):261-266. PubMed ID: 37130317
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic kidney disease stage is associated with the number of risk factors in type 2 diabetes patients (STages Of NEphropathy in type 2 diabetes and Heart Failure - STONE HF).
    Metsärinne K; Pietilä M; Kantola I; K Stenman L; Vesikansa A; Ruokolainen L; Niskanen L;
    Prim Care Diabetes; 2023 Dec; 17(6):632-638. PubMed ID: 37891057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
    Patel PA; Liang L; Khazanie P; Hammill BG; Fonarow GC; Yancy CW; Bhatt DL; Curtis LH; Hernandez AF
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of renal function in living kidney donors before and after nephrectomy: A Japanese prospective, observational cohort study.
    Kakuta Y; Imamura R; Okumi M; Horio M; Isaka Y; Ichimaru N; Takahara S; Nonomura N; Tanabe K
    Int J Urol; 2019 Apr; 26(4):499-505. PubMed ID: 30818421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease in Russia: the Ural eye and medical study.
    Bikbov MM; Zainullin RM; Kazakbaeva GM; Gilmanshin TR; Rakhimova EM; Rusakova IA; Bolshakova NI; Safiullina KR; Panda-Jonas S; Yakupova DF; Nikitin NA; Jonas JB
    BMC Nephrol; 2020 May; 21(1):198. PubMed ID: 32450794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.